Fundamental analysis by بورس24 | Bourse24 about Stock دکوثر on 8/28/2023

✅ "Decozar" received new product production licenses Kosar Pharmaceutical Company said the company has been able to obtain 8 new licenses for the production of cardiovascular and diabetic products, one of which is exclusively manufactured in 4 different doses and is first manufactured and supplied in Iran. Obviously, additional descriptions of the sale and profitability of these products were announced in the coming monthly and seasonal reports. 🔗 Read more ... @Bourse24ir